ALBRIGHT, CHARLES, F,BARTEN, DONNA, MARIE,LEE, FRANCIS, Y
申请号：
NZ58855509
公开号：
NZ588555A
申请日:
2009.04.24
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Disclosed herein is the use of epothilone D in the manufacture of a medicament, either formulated for intravenous or oral administration, for treating Alzheimers diseases or a Tau-associated disease in a human patient in need of treatment thereof, wherein the Tau-associated disease is selected from frontotemporal dementia with Parkinsonism linked with chromosome 17 (FTDP-17), progressive supranuclear palsy, corticobasal degeneration, Picks disease, agyrophilic grain disease, Down syndrome, myotonic dystrophy, Niemann-Pick C disease, dementia pugilistica, Blint disease, and traumatic brain injury.
